GlassScriptPhysician profile
Joshua Scott
NPI 1699158014
$1,900.37
in general payments reported to CMS, 2019-2025
15 companies · $1,073 in 2025
The $1,073 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $827 · 2025: $1,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,432 · Travel and Lodging: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.07 |
| Travel and Lodging | $468.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $987.76 | 2024-2025 | Chromophare F300, Flowtriever, Flowtriever Catheter, S |
| Inari Medical, INC. | $265.32 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pylant Medical | $157.46 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $113.03 | 2024-2025 | Farxiga, Andexxa, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.33 | 2024-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.30 | 2025 | Lifevest |
| Amgen INC. | $47.00 | 2024-2025 | Repatha |
| Abbott Laboratories | $45.33 | 2025 | Cardiomems |
| Getinge USA Sales, LLC | $32.86 | 2024 | Vasoview Hemopro 2 |
| Novartis Pharmaceuticals Corporation | $27.87 | 2025 | |
| Solventum Corporation | $25.93 | 2025 | Prevena |
| Medtronic, INC. | $25.22 | 2025 | Symplicity G3 |
| E.R. Squibb & Sons, L.L.C. | $21.44 | 2024 | Camzyos |
| Atricure, INC. | $19.27 | 2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Synergy Ablation System |
| Boston Scientific Corporation | $18.25 | 2025 | Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.